Financial Results - Alzamend Neuro, Inc. reported unaudited financial results for the six months ended October 31, 2024[5]. - The report does not include specific financial figures or performance metrics in the provided content[6]. Company Classification - The company is classified as an emerging growth company under the Securities Act of 1933[4]. Press Release - The press release detailing financial results was issued on December 12, 2024[5]. Forward-Looking Statements - The company emphasizes the importance of forward-looking statements regarding its future operating results[7]. - Investors are advised to not overly rely on forward-looking statements due to inherent uncertainties and risks[7]. Company Information - The company’s principal executive office is located in Atlanta, GA[2]. - The Chief Financial Officer, David J. Katzoff, signed the report[14]. Regulatory Compliance - The report includes a cover page formatted in Inline XBRL for regulatory compliance[10]. - Additional information can be accessed through the SEC's website[9].
Alzamend Neuro(ALZN) - 2025 Q2 - Quarterly Results